AAP
EVH icon

Arax Advisory Partners’s Evolent Health EVH Stock Holding History

Arax Advisory Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.8K Buy
7,720
+7,714
+128,567% +$29.6K ﹤0.01% 3417
2026
Q1 		$180 Buy
+6
New +$19 ﹤0.01% 3559
2025
Q4 		– Sell
-479
Closed -$4.05K – 4226
2025
Q3 		$4.05K Buy
+479
New +$4.65K ﹤0.01% 2927

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Arax Advisory Partners's EVH Position: Q2 2026 in Review

Arax Advisory Partners increased its Evolent Health (EVH) stake by 128,567% in Q2 2026, buying an estimated $29.6K and bringing the position to 7,720 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3417.

Arax Advisory Partners first reported a position in EVH in Q3 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Arax Advisory Partners held 7,720 shares of Evolent Health worth $41.8K as of Q2 2026.
  • Arax Advisory Partners bought 7,714 Evolent Health shares in Q2 2026, an estimated $29.6K.
  • Evolent Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3417 holding.
  • Arax Advisory Partners first reported a position in Evolent Health in Q3 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.